Obstructive Hypertrophic Cardiomyopathy: Getting it Right First Time
Published: 13 January 2023
19m 4sPart 1 When Should We Consider a Diagnosis of oHCM? - Presented by Dr Milind Desai Marc Dweck, Milind Y Desai, Carolyn Ho, Robin Nijveldt
15m 41sPart 2 Role of Echocardiography in Hypertrophic Cardiomyopathy - Presented by Prof Marc Dweck Marc Dweck, Milind Y Desai, Robin Nijveldt, Carolyn Ho
27m 16sPart 3 CMR: When to Use It - Presented by Prof Robin Nijveldt Marc Dweck, Milind Y Desai, Robin Nijveldt, Carolyn Ho
The on-demand version of this educational broadcast leverages an expert faculty to distil the importance of making correct and timely diagnosis of HCM and how to do it.
This video series leverages guidance from imaging experts in the HCM field to provide a practical approach to diagnosing HCM and considering best course of treatment.
Following attendance at this broadcast, physicians will be able to:
- Recall the general approach to diagnosis and stratification of HCM according to the latest guidelines and expert opinion
- Apply advanced echocardiographic methodologies to equivocal HCM diagnoses
- Select appropriate imaging modalities to facilitate accurate risk stratification
- Stratify patients based on specific risk features and disease severity
- Choose suitable treatment modalities for patients based on specific disease features and severity
- Cardiovascular imaging specialists
- Cardiology community
More from this programme
When Should We Consider a Diagnosis of oHCM?
Role of Echocardiography in Hypertrophic Cardiomyopathy
CMR: When to Use It
Phenotyping and Treatment Selection
Professor of Clinical Cardiology
Professor Marc Dweck is the Professor of Clinical Cardiology and Consultant at the University of Edinburgh, UK. He is an EACVI Board Member with clinical interests in multi-modality imaging and cardiac device implantation His research program is centred around the use of multi-modality imaging (echo, CT, CMR, PET) to improve our understanding of cardiovascular pathophysiology and ultimately to improve patient assessment, care and outcomes. In particular he has focused on coronary atherosclerosis, aortic stenosis and cardiomyopathy. He has published in many of the leading medical and cardiovascular journals and is the recipient of numerous national and international awards (e.g. Michael Davies Award; Sir Jules Thorn Award; BHF Outstanding Investigator Award, Parmley Prize JACC). He is currently the Chief Investigator of two ongoing RCTs trials of novel therapeutic strategies in aortic stenosis (SALTIRE 2 NCT02132026 & EVOLVED NCT03094143).
Milind Y Desai
Professor of Medicine
Dr Desai works in the Cardiovascular Medicine and Heart and Vascular Institute at the Cleveland Clinic.
He is the Director of Clinical Operations and Center for Hypertrophic Cardiomyopathy, the Medical Director of the Center for Aortic Diseases, the Medical Director for Center for Radiation Heart Disease and an integral part of the Center for Valvular heart disease.
Professor of Cardiovascular Imaging and Cardiologist
Prof Robin Nijveldt is Professor of Cardiovascular Imaging and Cardiologist at the Radboud University Medical Center in Nijmegen, NL and connected to the Radboud Institute for Health Sciences. He works at the department of Cardiology and focusses on the Vascular damage research theme, with a special interest in Cardiovascular Magnetic Resonance imaging, CT and echocardiography, and in close collaboration with the department of Radiology. He explores new imaging techniques and innovative strategies on today’s scientific health challenges, and aims to improve patient outcome in a personalised approach.
Dr Carolyn Ho is the medical director of the Cardiovascular Genetics Center at Brigham and Women’s Hospital. Dr Ho is also an associate professor of medicine at Harvard Medical School.
Dr Ho’s clinical interests include cardiomyopathy, echocardiography, and cardiovascular genetics.